Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by James Ford. Insider active across 1 company, notably GSK plc. Aggregated, 129 disclosures have been logged. History available since 9 August 2023. The latest transaction was filed on 11 August 2026 (Purchase). Regulator: RNS (LSE). All data is free.
Companies and markets linked to James Ford Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 129 total
● SVP and Group General Counsel, Legal and Compliance · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9721245-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 14 Jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9673287-0 ● SVP and Group General Counsel, Legal and Compliance · Executives · 14 Jul 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-0 ● SVP and Group General Counsel, Legal and Compliance · Executives · 10 Jul 2026 · GSK plc 688 shares @ £19.595 0.0018% mcap 0.1% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-17 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jul 2026 · GSK plc 1,789.579 shares @ £19.6297 0.0046% mcap 0.2% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jul 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jul 2026 · GSK plc 11 shares @ £19.6291 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-11 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jul 2026 · GSK plc 11 shares @ £19.6291 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-11 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9614374-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 15 May 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9576175-1 ● SVP and Group General Counsel, Legal and Compliance · Executives · 15 May 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:0c2b3473-feab-43c0-81c0-8a4af4e4f91f-1 ● SVP and Group General Counsel, Legal and Compliance · Executives · 12 May 2026 · GSK plc 14 shares @ £18.778 0.0000% mcap 100.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9569357-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 14 Apr 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-17 ● SVP and Group General Counsel, Legal and Compliance · Executives · 14 Apr 2026 · GSK plc 653 shares @ £21.67 0.0000% mcap 0.1% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 13 Apr 2026 · GSK plc 10 shares @ £21.709 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Apr 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-8 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Apr 2026 · GSK plc 10 shares @ £21.339 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-2 ● SVP and Group General Counsel, Legal and Compliance · Executives · 20 Feb 2026 · GSK plc 0
New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:fe9ff3d0-496f-4133-bff2-48fa547745d3-1 ● SVP and Group General Counsel, Legal and Compliance · Executives · 13 Feb 2026 · GSK plc 159,845 shares 0
N/AISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-8 25 of 129 declarations
Load more (104 remaining) About James Ford James Ford is a declarant linked to GSK plc, where he holds the role of SVP and Group General Counsel, Legal and Compliance. He has 93 filings in total, and across the sampled recent filings, the reported buy volume is EUR 12378 and the reported sell volume is EUR 8072972, over the period from 2023-08-10 to 2026-06-12.